- Oculus Innovative Sciences Announces Additional Phase II Data for ... - Ad-Hoc-News (Pressemitteilung)
- Abraxis BioScience Reports 83% Revenue Growth to a Record $334 ... - FOXBusiness
- StemCyte Announces Joint Venture With Two Leading Healthcare and ... - Biloxi Sun Herald
- PAREXEL International Expands Relationship with Synchron Research ... - Biloxi Sun Herald
- Abraxis BioScience Reports Financial Results for the Second ... - istockAnalyst.com
Human Genome Sciences Reports Initial Results of Randomized Phase ... - Biloxi Sun Herald
Human Genome Sciences Reports Initial Results of Randomized Phase ...Biloxi Sun Herald, USA - 9 hours ago2 -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today reported initial topline results from an ongoing randomized Phase 2 clinical trial of its TRAIL ...
